After staying slightly below the flat line till a little past mid-morning, the European market drifted down and eventually ended moderately lower on Wednesday.
The benchmark SMI, which dropped to a low of 14,068.50 ended the day at 14,114.00, losing 79.92 points or 0.56%.
Galderma Group ended 2.75% down. The delay in getting the U.S. FDA’s nod for the company’s Relfydess neuromodulator weighed on the stock.
Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial – No Payment Required
Market Analysis
Swiss Market Ends Moderately Lower
2026-07-01 17:55:00
